Cardiologie
![HCM Cardiologie](/sites/default/files/2023-02/HCM%20Cardiologie%20-%20Rotterdam%20-%20Copy.jpg)
![HCM Cardiologie](/sites/default/files/2023-02/HCM%20Cardiologie%20-%20Rotterdam%20-%20Copy.jpg)
Het belangrijkste doel van farmacologische behandelingen is om de impact op het dagelijks leven van HCM te verminderen5
![Diagnose Card](/sites/default/files/2023-02/Diagnose%20Card.png)
Comorbiditeiten en sterfte
Wat zijn de mogelijke complicaties van HCM? Lees meer over het risico op comorbiditeiten en sterfte.
![Diagnose](/sites/default/files/2023-02/Behandeling%20van%20HCM.png)
Diagnose
Lees hier over de diagnose van HCM.
Meer weten over HCM
Referenties
1. Huff CM, Turer AT, Wang A. Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy. Qual Life Res. 2013;22(3):647-652.
2. Cox S, O’Donoghue AC, McKenna WJ, Steptoe A. Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart. 1997;78(2):182-187.
3. Zaiser E, Sehnert AJ, Duenas A, Saberi S, Brookes E, Reaney M. Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life. J Patient Rep Outcomes. 2020;4(1 ):102.
4. Luiten RC, Ormond K, Post L, Asif IM, Wheeler MT, Caleshu C. Exercise restrictions trigger psychological difficulty in active and athletic adults with hypertrophic cardiomyopathy. Open Heart. 2016;3(2):e000488.
5. Ammirati E, Contri R, Coppini R, Cecchi F, Frigerio M, Olivotto I. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives. EurJ Heart Fail. 2016;18(9):1106-1118.